JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer. - Alexandrou, Sarah; Lee, Christine S.; Fernandez, Kristine J.; Wiharja, Celine E.; Eshraghi, Leila; Reeves, John; Reed, Daniel A.; Portman, Neil; Phan, Zoe; Milioli, Heloisa H.; Nikolic, Iva; Cadell, Antonia L.; et al. (Journal of Experimental & Clinical Cancer Research (17569966), 2025)